RASSF6; the Putative Tumor Suppressor of the RASSF Family
AbstractHumans have 10 genes that belong to the Ras association (RA) domain family (RASSF). Among them, RASSF7 to RASSF10 have the RA domain in the N-terminal region and are called the N-RASSF proteins. In contradistinction to them, RASSF1 to RASSF6 are referred to as the C-RASSF proteins. The C-RASSF proteins have the RA domain in the middle region and the Salvador/RASSF/Hippo domain in the C-terminal region. RASSF6 additionally harbors the PSD-95/Discs large/ZO-1 (PDZ)-binding motif. Expression of RASSF6 is epigenetically suppressed in human cancers and is generally regarded as a tumor suppressor. RASSF6 induces caspase-dependent and -independent apoptosis. RASSF6 interacts with mammalian Ste20-like kinases (homologs of Drosophila Hippo) and cross-talks with the Hippo pathway. RASSF6 binds MDM2 and regulates p53 expression. The interactions with Ras and Modulator of apoptosis 1 (MOAP1) are also suggested by heterologous protein-protein interaction experiments. RASSF6 regulates apoptosis and cell cycle through these protein-protein interactions, and is implicated in the NF-κB and JNK signaling pathways. We summarize our current knowledge about RASSF6 and discuss what common and different properties RASSF6 and the other C-RASSF proteins have. View Full-Text
Share & Cite This Article
Iwasa, H.; Jiang, X.; Hata, Y. RASSF6; the Putative Tumor Suppressor of the RASSF Family. Cancers 2015, 7, 2415-2426.
Iwasa H, Jiang X, Hata Y. RASSF6; the Putative Tumor Suppressor of the RASSF Family. Cancers. 2015; 7(4):2415-2426.Chicago/Turabian Style
Iwasa, Hiroaki; Jiang, Xinliang; Hata, Yutaka. 2015. "RASSF6; the Putative Tumor Suppressor of the RASSF Family." Cancers 7, no. 4: 2415-2426.